STI-7349 Clinical Trials

1 actively recruiting trial

Also known as: IL2v mRNA

Pipeline

Phase 1/2: 1

Top Sponsors

The Fourth Affiliated Hospital of Zhejiang University School of Medicine1

Indications

Advanced Solid Tumor1
Cancer1

Other1 trial

A Dose Escalation and Dose Expansion Clinical Study of STI-7349 in Subjects With Advanced Solid Tumors

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.